Comparison of the Healing Effect of Nasal Saline Irrigation with Triamcinolone Acetonide Versus Nasal Saline Irrigation alone in COVID-19 Related Olfactory Dysfunction: A Randomized Controlled Study

• Published in: Indian journal of otolaryngology, and head, and neck surgery and head, and neck surgery, 2022-10, Vol.74 (Suppl 2), p.3022-3027
• Main Authors: Yildiz, Erkan, Koca Yildiz, Selcen, Kuzu, Selçuk, Günebakan, Çağlar, Bucak, Abdulkadir, Kahveci, Orhan Kemal
• Format: Article
• Language: English
• Subjects: Coronaviruses; COVID-19; Head and Neck Surgery; Medicine; Medicine & Public Health; Olfaction disorders; Original; Original Article; Otorhinolaryngology; Steroids
• ISSN: 2231-3796; 0973-7707
• DOI: 10.1007/s12070-021-02749-9

There is no routinely determined treatment for olfactory dysfunction because of COVID-19. Saline irrigation and nasal corticosteroid treatments are safe and inexpensive methods, and have low side effects. In our study, we argue that saline nasal irrigation and topical corticosteroid treatment can be used in the treatment of patients with olfactory loss in all areas of rhinology. A total of 150 patients who admitted to our clinic with other symptoms or with only acute odor loss, diagnosed with COVID-19 with RT-PCR were divided into 3 equal groups.Fifty patients in Group 1 were not given any extra treatments. The other 50 patients in Group 2 were given saline irrigation for treatment; and the 50 people in Group 3 were given both saline irrigation and nasal steroid spray for treatment. The “Subjective Olfactory Capability (SOC)” was used for olfactory function evaluation of patients. Self-Rating Olfactory Score (SROS), and Olfactory Dysfunction Duration (ODD) were recorded on the 1st, 15th and 30th days. SROS of the group receiving Nasal Saline + Triamcinolone Acetonide treatment on the 30th day was significantly higher than in other groups ( p −1–3  = 0.018,  p 2−3  = 0.033 ). Also, the ODD was significantly reduced in this group compared to other groups  ( p −1–3  = 0.022,  p 2−3  = 0.028,). Topical triamcinolone treatment was found to be successful in the treatment of olfactory dysfunction due to COVID-19. Nasal steroids, which are both inexpensive and have low side effect profiles, can be used safely in the treatment of patients with olfactory losses.